William Mitchell
Chairman at AIM IMMUNOTECH INC.
Net worth: 35 990 $ as of 2024-03-30
Profile
William M.
Mitchell is the founder of ActivBiotics, Inc. (founded in 1996).
He is currently the Chairman at AIM ImmunoTech, Inc. (since 1998), a Member at the American Medical Association, and a Professor at Vanderbilt University School of Medicine.
Previously, he served as the Director at AIM ImmunoTech, Inc. (1987-1989) and as a Non-Executive Director at Chronix Biomedical, Inc. Dr. Mitchell holds a doctorate degree from The Johns Hopkins University and Vanderbilt University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AIM IMMUNOTECH INC.
0.16% | 2023-10-01 | 76,412 ( 0.16% ) | 35 990 $ | 2024-03-30 |
William Mitchell active positions
| Companies | Position | Start |
|---|---|---|
| AIM IMMUNOTECH INC. | Chairman | 2016-02-16 |
American Medical Association
 American Medical Association Miscellaneous Commercial ServicesCommercial Services American Medical Association engages in promoting the art and science of medicine and the betterment of public health. It offers services to physicians, residents, medical students, and patients. The company was founded by Nathan Smith Davis in 1847 and is headquartered in Chicago, IL. | Corporate Officer/Principal | - |
| Vanderbilt University School of Medicine | Corporate Officer/Principal | - |
Former positions of William Mitchell
| Companies | Position | End |
|---|---|---|
| AIM IMMUNOTECH INC. | Director/Board Member | 1988-12-31 |
ActivBiotics, Inc.
 ActivBiotics, Inc. BiotechnologyHealth Technology ActivBiotics, Inc. discovers and develops pharmaceutical drugs. It provides discovery, development, and commercialization of therapies for the treatment of vascular disease, inflammation, and other high-value chronic and infectious diseases. The company was founded in 1996 and is headquartered in Lexington, MA. | Founder | - |
Chronix Biomedical, Inc.
 Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Director/Board Member | - |
Training of William Mitchell
| The Johns Hopkins University | Doctorate Degree |
| Vanderbilt University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AIM IMMUNOTECH INC. | Health Technology |
| Private companies | 3 |
|---|---|
American Medical Association
American Medical Association Miscellaneous Commercial ServicesCommercial Services American Medical Association engages in promoting the art and science of medicine and the betterment of public health. It offers services to physicians, residents, medical students, and patients. The company was founded by Nathan Smith Davis in 1847 and is headquartered in Chicago, IL. | Commercial Services |
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Health Technology |
ActivBiotics, Inc.
ActivBiotics, Inc. BiotechnologyHealth Technology ActivBiotics, Inc. discovers and develops pharmaceutical drugs. It provides discovery, development, and commercialization of therapies for the treatment of vascular disease, inflammation, and other high-value chronic and infectious diseases. The company was founded in 1996 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- William Mitchell
